1. Home
  2. Analysis
  3. Grape-seed-extract
  4. Compazine

Grape seed extract and Compazine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Grape seed extract and Compazine. Common interactions include pyrexia among females and dermatitis allergic among males.

The phase IV clinical study analyzes what interactions people who take Grape seed extract and Compazine have. It is created by eHealthMe based on reports of 6 people who take Grape seed extract and Compazine from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Dec, 02, 2022

6 people who take Grape seed extract and Compazine together, and have interactions are studied.

What is Grape seed extract?

Grape seed extract has active ingredients of grape. eHealthMe is studying from 464 Grape seed extract users for its effectiveness, alternative drugs and more.

What is Compazine?

Compazine has active ingredients of prochlorperazine maleate. It is often used in nausea and vomiting. eHealthMe is studying from 11,943 Compazine users for its effectiveness, alternative drugs and more.

Number of Grape seed extract and Compazine reports submitted per year:

Grape seed extract and Compazine drug interactions.

Common Grape Seed Extract and Compazine drug interactions by gender *:

female:

  1. Pyrexia
  2. Dizziness
  3. Dyspnoea exertional
  4. Fall
  5. Fatigue
  6. Insomnia
  7. Malaise
  8. Oedema peripheral
  9. Pain
  10. Splenomegaly

male:

  1. Dermatitis allergic

Common Grape Seed Extract and Compazine drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Attention deficit hyperactivity disorder

50-59:

  1. Cellulitis
  2. Hypersensitivity
  3. Nail infection
  4. Pyrexia
  5. Rash erythematous
  6. Tinea pedis

60+:

  1. Anaemia
  2. Anxiety
  3. Fall
  4. Fatigue
  5. Insomnia
  6. Malaise
  7. Oedema peripheral
  8. Pain
  9. Pyrexia
  10. Splenomegaly

* Approximation only. Some reports may have incomplete information.

Do you take Grape seed extract and Compazine?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Grape seed extract and Compazine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Grape seed extract side effects:

Browse all side effects of Grape seed extract:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Compazine side effects:

Browse all side effects of Compazine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Grape seed extract interactions:

Browse all interactions between Grape seed extract and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Compazine interactions:

Browse all interactions between Compazine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on grape and prochlorperazine maleate (the active ingredients of Grape seed extract and Compazine, respectively), and Grape seed extract and Compazine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Grape seed extract and Compazine.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.